These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 34169445

  • 1. Chlorhexidine leads to the evolution of antibiotic-resistant Pseudomonas aeruginosa.
    Tag ElDein MA, Yassin AS, El-Tayeb O, Kashef MT.
    Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2349-2361. PubMed ID: 34169445
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
    Choudhury D, Das Talukdar A, Dutta Choudhury M, Maurya AP, Paul D, Dhar Chanda D, Chakravorty A, Bhattacharjee A.
    PLoS One; 2015 Nov; 10(7):e0133842. PubMed ID: 26221722
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
    Goli HR, Nahaei MR, Rezaee MA, Hasani A, Kafil HS, Aghazadeh M, Nikbakht M, Khalili Y.
    J Infect Public Health; 2018 Nov; 11(3):364-372. PubMed ID: 28993173
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.
    Dean CR, Visalli MA, Projan SJ, Sum PE, Bradford PA.
    Antimicrob Agents Chemother; 2003 Mar; 47(3):972-8. PubMed ID: 12604529
    [Abstract] [Full Text] [Related]

  • 10. Meropenem potentiation of aminoglycoside activity against Pseudomonas aeruginosa: involvement of the MexXY-OprM multidrug efflux system.
    Poole K, Gilmour C, Farha MA, Parkins MD, Klinoski R, Brown ED.
    J Antimicrob Chemother; 2018 May 01; 73(5):1247-1255. PubMed ID: 29420743
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Vettoretti L, Plésiat P, Muller C, El Garch F, Phan G, Attrée I, Ducruix A, Llanes C.
    Antimicrob Agents Chemother; 2009 May 01; 53(5):1987-97. PubMed ID: 19258280
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.
    Adamson DH, Krikstopaityte V, Coote PJ.
    J Antimicrob Chemother; 2015 Aug 01; 70(8):2271-8. PubMed ID: 25921513
    [Abstract] [Full Text] [Related]

  • 18. The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin.
    Puja H, Bolard A, Noguès A, Plésiat P, Jeannot K.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31964794
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.